EASL policy statement on the coexistence of non-alcoholic fatty liver disease and alcohol-related liver disease
At Digital ILC 2020, EASL is launching a policy paper with its accompanying lay summary, to inform politicians, policymakers, and the general population about the two leading causes of liver disease in…
Digital ILC 2020 delegates can get creative in the #EASLshare competition
24 August 2020 Share your best #EASLshare and win free registrations and more for ILC 2021. EASL is encouraging Digital ILC 2020 delegates to take part in the first ever EASL Share…
EASL–ESCMID Position Paper: a review, six months into the pandemic
Six months into the COVID-19 pandemic, an article has been published to provide guidance for physicians involved in the care of patients with chronic liver disease. 5 August 2020 – Geneva, Switzerland:…
Liver enthusiasts who paved the way: 50 years of the Gnomes
Professional societies play a major role in medicine and science. These societies tend to be large, with well-developed administrative structures. An additional model, however, is based on small groups of experts who…
Tribute to Prof. Roger Williams
It is with great sadness that EASL announces the passing of Prof. Roger Williams, a pioneer in liver disease and an inspiration to the world of hepatology. We send our sincere condolences…
EASL declares ongoing commitment to fighting hepatitis
Every year, the World Hepatitis Day brings the world together to focus on the theme of raising awareness about the global burden of viral hepatitis (inflammation of the liver), and to advocate…
Explore the Viral Hepatitis track at Digital ILC 2020
The curative potential of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection have transformed hepatology in recent years. However, the challenge of identifying more people living with HCV remains, and further…